Related Experiment Videos
AMPA- and NMDA-associated postsynaptic protein expression in the human dorsolateral prefrontal cortex
Monica Beneyto1, James H Meador-Woodruff
1Mental Health Research Institute and Department of Psychiatry, University of Michigan, Ann Arbor, Michigan 48109, USA. mbeneyto@umich.edu
Annals of the New York Academy of Sciences
|December 20, 2003
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Differential genetic associations and expression of PAPST1/SLC35B2 in bipolar disorder and schizophrenia.
Journal of neural transmission (Vienna, Austria : 1996)·2022
mTOR kinase activity disrupts a phosphorylation signaling network in schizophrenia brain.
Molecular psychiatry·2021
Post-translational protein modifications in schizophrenia.
NPJ schizophrenia·2020
Protein expression of prenyltransferase subunits in postmortem schizophrenia dorsolateral prefrontal cortex.
Translational psychiatry·2020
Spatial Coherence Structure-Mediated Transmission of Encrypted Three-Dimensional Objects and Hidden Information.
Annals of the New York Academy of Sciences·2026
A Graph Network-Based Real-Time Precise Predicting Model for Progressive Collapse of Steel Frame Structures.
Annals of the New York Academy of Sciences·2026
Protégé Effect for Behavior Change: Does Teaching Digital Stress Solutions to Others Reduce One's Own?
Annals of the New York Academy of Sciences·2026
Early Ocular Response to Visual Motion in Patients With Persistent Postural-Perceptual Dizziness.
Annals of the New York Academy of Sciences·2026
Pain Expectation in Individuals With High Autistic Traits: Decision-Evaluation Processes and Oxytocin Modulation.
Annals of the New York Academy of Sciences·2026
Design of an Adaptive Model for Intelligent Car Seats Based on Human Pose Recognition.
Annals of the New York Academy of Sciences·2026
Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.
Canadian journal of kidney health and disease·2026
Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.
Therapeutic advances in neurological disorders·2026